Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Physiological Sciences : JPS|March 9, 2019
Effects of chronic Porphyromonas gingivalis lipopolysaccharide infusion on skeletal muscles in miceNaoya Kawamura, Yoshiki Ohnuki, Ichiro Matsuo, et al.
Physiological Reports|November 24, 2025
Transcription factor MITF regulates masseter muscle growth and developmentMegumi Nariyama, Yoshiki Ohnuki, Kenji Suita, et al.
Plos One|June 1, 2022
Role of TLR4 signaling on Porphyromonas gingivalis LPS-induced cardiac dysfunction in miceIchiro Matsuo, Naoya Kawamura, Yoshiki Ohnuki, et al.
Physiological Reports|May 22, 2016
Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterolYoshiki Ohnuki, Daisuke Umeki, Yasumasa Mototani, et al.
Plos One|July 28, 2020
Effects of occlusal disharmony on cardiac fibrosis, myocyte apoptosis and myocyte oxidative DNA damage in miceYuka Yagisawa, Kenji Suita, Yoshiki Ohnuki, et al.
Scientific Reports|June 23, 2026
Role of β-adrenergic signaling in the development of Porphyromonas gingivalis lipopolysaccharide-induced cardiac dysfunction in miceIchiro Matsuo, Kenji Suita, Yoshiki Ohnuki, et al.
The Journal of Physiological Sciences : JPS|December 21, 2016
Epac activation inhibits IL-6-induced cardiac myocyte dysfunctionHuiling Jin, Takayuki Fujita, Meihua Jin, et al.
The Journal of Physiological Sciences : JPS|February 15, 2019
Correction to: Epac activation inhibits IL-6-induced cardiac myocyte dysfunctionHuiling Jin, Takayuki Fujita, Meihua Jin, et al.
The Journal of Physiological Sciences : JPS|January 15, 2015
Oscillation of cAMP and Ca(2+) in cardiac myocytes: a systems biology approachTakehisa Kamide, Satoshi Okumura, Samik Ghosh, et al.
Plos One|April 3, 2025
Allopurinol attenuates development of Porphyromonas gingivalis LPS-induced cardiomyopathy in miceAkinaka Morii, Ichiro Matsuo, Kenji Suita, et al.
Pageof 5